Helius Medical Technologies (HSDT) Competitors

$0.70

-0.08 (-10.22%)

(As of 07/26/2024 ET)

HSDT vs. GCTK, SONX, INBS, LUCY, STSS, SINT, BIOL, AVGR, TNON, and BBLG

Should you be buying Helius Medical Technologies stock or one of its competitors? The main competitors of Helius Medical Technologies include GlucoTrack (GCTK), Sonendo (SONX), Intelligent Bio Solutions (INBS), Innovative Eyewear (LUCY), Sharps Technology (STSS), Sintx Technologies (SINT), BIOLASE (BIOL), Avinger (AVGR), Tenon Medical (TNON), and Bone Biologics (BBLG). These companies are all part of the "medical equipment" industry.

Helius Medical Technologies vs.

Helius Medical Technologies (NASDAQ:HSDT) and GlucoTrack (NASDAQ:GCTK) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their profitability, risk, media sentiment, community ranking, dividends, institutional ownership, analyst recommendations, earnings and valuation.

: Helius Medical Technologies received 20 more outperform votes than GlucoTrack when rated by MarketBeat users.
Company Underperform Outperform
Helius Medical Technologies Outperform Votes
20
57.14%
Underperform Votes
15
42.86%
GlucoTrack N/A N/A
: GlucoTrack has lower revenue, but higher earnings than Helius Medical Technologies. GlucoTrack is trading at a lower price-to-earnings ratio than Helius Medical Technologies, indicating that it is currently the more affordable of the two stocks.
Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Helius Medical Technologies $640K 3.25 -$8.85M -$13.04 -0.05
GlucoTrack N/A N/A -$7.10M -$2.05 -0.66
: 18.6% of Helius Medical Technologies shares are owned by institutional investors. Comparatively, 10.9% of GlucoTrack shares are owned by institutional investors. 5.1% of Helius Medical Technologies shares are owned by company insiders. Comparatively, 17.7% of GlucoTrack shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.
: GlucoTrack has a net margin of 0.00% compared to Helius Medical Technologies' net margin of -1,328.14%. GlucoTrack's return on equity of -207.55% beat Helius Medical Technologies' return on equity.
Company Net Margins Return on Equity Return on Assets
Helius Medical Technologies -1,328.14% -297.49% -107.36%
GlucoTrack N/A -207.55% -151.03%
: Helius Medical Technologies currently has a consensus price target of $24.00, indicating a potential upside of 3,313.94%. Given Helius Medical Technologies' higher possible upside, equities research analysts clearly believe Helius Medical Technologies is more favorable than GlucoTrack.
Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Helius Medical Technologies
0 Sell rating(s)
0 Hold rating(s)

1 Buy rating(s)

0 Strong Buy rating(s)
3.00
GlucoTrack
0 Sell rating(s)

0 Hold rating(s)

0 Buy rating(s)

0 Strong Buy rating(s)
N/A
: Helius Medical Technologies has a beta of 1.6, suggesting that its stock price is 60% more volatile than the S&P 500. Comparatively, GlucoTrack has a beta of 0.06, suggesting that its stock price is 94% less volatile than the S&P 500.
: In the previous week, Helius Medical Technologies and Helius Medical Technologies both had 2 articles in the media. GlucoTrack's average media sentiment score of 1.43 beat Helius Medical Technologies' score of 0.29 indicating that GlucoTrack is being referred to more favorably in the news media.
Company Overall Sentiment
Helius Medical Technologies Neutral
GlucoTrack Positive

Company	Underperform	Outperform
Helius Medical Technologies	Outperform Votes 20 57.14%	Underperform Votes 15 42.86%
GlucoTrack	N/A	N/A

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Helius Medical Technologies	$640K	3.25	-$8.85M	-$13.04	-0.05
GlucoTrack	N/A	N/A	-$7.10M	-$2.05	-0.66

Company	Net Margins	Return on Equity	Return on Assets
Helius Medical Technologies	-1,328.14%	-297.49%	-107.36%
GlucoTrack	N/A	-207.55%	-151.03%

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Helius Medical Technologies	0 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	3.00
GlucoTrack	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	N/A

Company	Overall Sentiment
Helius Medical Technologies	Neutral
GlucoTrack	Positive

Summary

Helius Medical Technologies beats GlucoTrack on 8 of the 14 factors compared between the two stocks.

Ad Porter & Company

My grim warning about AI stocks

Today, I’m warning of another looming catastrophe. Only this time, it’s not in pot stocks, cryptos, or U.S. housing… it's in artificial intelligence. And unless you know what’s really going on in this sector, you could be wiped out. You see, while there is no doubt that the recent advancements in artificial intelligence are game-changing and will drive colossal innovation in every sector of the economy... There's also no escaping that The Big AI Die-Up is coming.

So go here now to read my new report The Big AI Die-Up… while you still can.

Get Helius Medical Technologies News Delivered to You Automatically

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding HSDT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

HSDT vs. The Competition

Export to Excel

Metric	Helius Medical Technologies	Electromedical equipment Industry	Medical Sector	NASDAQ Exchange
Market Cap	$2.08M	$3.08B	$5.32B	$8.21B
Dividend Yield	N/A	1.72%	2.72%	3.97%
P/E Ratio	-0.05	9.41	157.66	18.66
Price / Sales	3.25	50.08	2,090.54	91.84
Price / Cash	N/A	74.00	35.75	34.11
Price / Book	0.21	3.84	4.95	4.51
Net Income	-$8.85M	$86.88M	$112.16M	$216.36M
7 Day Performance	-17.29%	-2.72%	2.71%	1.82%
1 Month Performance	-29.69%	-4.24%	6.96%	7.09%
1 Year Performance	-93.34%	-2.18%	11.17%	4.89%

Helius Medical Technologies Competitors List

Export to Excel

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
GCTK GlucoTrack	0 of 5 stars 0.00 / 5 stars	$1.36 -4.2%	N/A	-12.1%	$7.45M	N/A	-0.66	5	Short Interest ↓
SONX Sonendo	0.8488 of 5 stars 0.85 / 5 stars	$0.07 flat	$1.88 +2,433.8%	-94.3%	$5.22M	$44.40M	-0.13	250	Gap Down
INBS Intelligent Bio Solutions	1.0453 of 5 stars 1.05 / 5 stars	$1.50 +6.4%	N/A	-94.5%	$4.68M	$1.26M	-0.04	10	Short Interest ↓ Positive News
LUCY Innovative Eyewear	1.8559 of 5 stars 1.86 / 5 stars	$5.24 +0.6%	$20.00 +281.7%	-68.4%	$4.61M	$1.15M	0.00	9	Stock Split Short Interest ↑ Gap Down
STSS Sharps Technology	0 of 5 stars 0.00 / 5 stars	$0.29 -3.3%	N/A	-65.8%	$4.54M	N/A	-0.48	3	Short Interest ↑
SINT Sintx Technologies	0 of 5 stars 0.00 / 5 stars	$5.27 +6.0%	N/A	-98.3%	$3.22M	$2.63M	-0.01	40	News Coverage
BIOL BIOLASE	1.0942 of 5 stars 1.09 / 5 stars	$0.08 +14.7%	$0.40 +412.8%	-98.8%	$2.86M	$49.16M	-0.01	160	Analyst Forecast
AVGR Avinger	3.0959 of 5 stars 3.10 / 5 stars	$1.42 -11.8%	$5.00 +252.1%	-87.9%	$2.41M	$7.65M	-0.08	70	Short Interest ↓ Gap Down High Trading Volume
TNON Tenon Medical	1.4125 of 5 stars 1.41 / 5 stars	$0.64 +3.2%	$3.00 +370.3%	+114.8%	$2.41M	$2.93M	-0.10	8	Short Interest ↑
BBLG Bone Biologics	0.7696 of 5 stars 0.77 / 5 stars	$1.99 -4.8%	N/A	N/A	$2.19M	N/A	0.00	2	Short Interest ↑ News Coverage Gap Up